Prostate-Specific Membrane Antigen-Avid Neurofibroma Mimicking Cutaneous Metastasis in Metastatic Castration-Resistant Prostate Cancer on 18 F-PSMA-1007 PET/CT

Clin Nucl Med. 2024 Jun 1;49(6):e286-e287. doi: 10.1097/RLU.0000000000005228. Epub 2024 Apr 8.

Abstract

The occurrence of cutaneous metastases in prostate cancer is exceedingly rare. Many benign lesions and nonprostatic cancers can express the prostate-specific membrane antigen (PSMA). They can potentially mimic metastasis of prostate cancer and lead to misinterpretation of PSMA PET/CT findings. Additionally, it has significant management and prognostic implications. We present a rare case of an 88-year-old man with metastatic castration-resistant prostate cancer who showed a PSMA-expressing subcutaneous nodule in the scalp on 18 F-PSMA-1007 PET/CT, raising the suspicion of cutaneous metastasis. However, its biopsy revealed a neurofibroma, altering the disease prognosis and management.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antigens, Surface / metabolism
  • Diagnosis, Differential
  • Fluorine Radioisotopes
  • Glutamate Carboxypeptidase II / metabolism
  • Humans
  • Male
  • Neurofibroma* / diagnostic imaging
  • Niacinamide / analogs & derivatives*
  • Oligopeptides
  • Positron Emission Tomography Computed Tomography*
  • Prostatic Neoplasms, Castration-Resistant* / diagnostic imaging
  • Prostatic Neoplasms, Castration-Resistant* / pathology
  • Skin Neoplasms* / diagnostic imaging
  • Skin Neoplasms* / pathology
  • Tomography, X-Ray Computed

Substances

  • PSMA-1007
  • Oligopeptides
  • Niacinamide
  • Glutamate Carboxypeptidase II
  • Antigens, Surface
  • FOLH1 protein, human
  • Fluorine Radioisotopes